These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8607674)

  • 21. Veno-venous bypass in liver transplantation: heparin-coated perfusion circuits reduce the activation of humoral defense systems in an in vitro model.
    Scholz T; Solberg R; Okkenhaug C; Videm V; Gallimore MJ; Mathisen O; Pedersen T; Mollnes TE; Bergan A; Søreide O; Klintmalm GB; Aasen AO
    Perfusion; 2001 Jul; 16(4):285-92. PubMed ID: 11486847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced complement activation and improved postoperative performance after cardiopulmonary bypass with heparin-coated circuits.
    Jansen PG; te Velthuis H; Huybregts RA; Paulus R; Bulder ER; van der Spoel HI; Bezemer PD; Slaats EH; Eijsman L; Wildevuur CR
    J Thorac Cardiovasc Surg; 1995 Sep; 110(3):829-34. PubMed ID: 7564452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparin coating of extracorporeal circuits inhibits contact activation during cardiac operations.
    te Velthuis H; Baufreton C; Jansen PG; Thijs CM; Hack CE; Sturk A; Wildevuur CR; Loisance DY
    J Thorac Cardiovasc Surg; 1997 Jul; 114(1):117-22. PubMed ID: 9240301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations.
    Videm V; Svennevig JL; Fosse E; Semb G; Osterud A; Mollnes TE
    J Thorac Cardiovasc Surg; 1992 Apr; 103(4):806-13. PubMed ID: 1548925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eosinophil granule major basic protein regulates generation of classical and alternative-amplification pathway C3 convertases in vitro.
    Weiler JM; Gleich GJ
    J Immunol; 1988 Mar; 140(5):1605-10. PubMed ID: 3346544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical performance and biocompatibility of novel hyaluronan-based heparin-bonded extracorporeal circuits.
    Gunaydin S; Mccusker K; Vijay V
    J Extra Corpor Technol; 2005 Sep; 37(3):290-5. PubMed ID: 16350383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
    Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparin-coated cardiopulmonary bypass circuits selectively deplete the pattern recognition molecule ficolin-2 of the lectin complement pathway in vivo.
    Hein E; Munthe-Fog L; Thiara AS; Fiane AE; Mollnes TE; Garred P
    Clin Exp Immunol; 2015 Feb; 179(2):294-9. PubMed ID: 25174443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass.
    Cavarocchi NC; Schaff HV; Orszulak TA; Homburger HA; Schnell WA; Pluth JR
    Surgery; 1985 Sep; 98(3):525-31. PubMed ID: 3875906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of methylprednisolone on complement activation during heparin neutralization.
    Loubser PG
    J Cardiovasc Pharmacol; 1997 Jan; 29(1):23-7. PubMed ID: 9007666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complement activation during major operations with or without cardiopulmonary bypass.
    Fosse E; Mollnes TE; Ingvaldsen B
    J Thorac Cardiovasc Surg; 1987 Jun; 93(6):860-6. PubMed ID: 3494886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations.
    Ovrum E; Tangen G; Oystese R; Ringdal MA; Istad R
    J Thorac Cardiovasc Surg; 2001 Feb; 121(2):324-30. PubMed ID: 11174738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcome after coronary surgery with heparin-coated extracorporeal circuits for cardiopulmonary bypass.
    Baufreton C; Le Besnerais P; Jansen P; Mazzucotelli JP; Wildevuur CR; Loisance DY
    Perfusion; 1996 Nov; 11(6):437-43. PubMed ID: 8971943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance.
    Ovrum E; Am Holen E; Tangen G; Ringdal MA
    Ann Thorac Surg; 1996 Oct; 62(4):1128-33. PubMed ID: 8823101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin-coated cardiopulmonary bypass equipment. I. Biocompatibility markers and development of complications in a high-risk population.
    Videm V; Mollnes TE; Fosse E; Mohr B; Bergh K; Hagve TA; Aasen AO; Svennevig JL
    J Thorac Cardiovasc Surg; 1999 Apr; 117(4):794-802. PubMed ID: 10096976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biocompatibility of heparin-coated circuits used in cardiopulmonary bypass.
    Pekna M; Borowiec J; Fagerhol MK; Venge P; Thelin S
    Scand J Thorac Cardiovasc Surg; 1994; 28(1):5-11. PubMed ID: 7939508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in blood activation related to roller/centrifugal pumps and heparin-coated/uncoated surfaces in a cardiopulmonary bypass model circuit.
    Moen O; Fosse E; Bråten J; Andersson C; Høgåsen K; Mollnes TE; Venge P; Kierulf P
    Perfusion; 1996 Mar; 11(2):113-23. PubMed ID: 8740352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does heparin coating improve biocompatibility? A study on complement, blood cells and postoperative morbidity during cardiac surgery.
    Belboul A; al-Khaja N
    Perfusion; 1997 Nov; 12(6):385-91. PubMed ID: 9413851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of sodium nitroprusside on complement activation induced by cardiopulmonary bypass: a clinical and experimental study.
    Seghaye MC; Duchateau J; Grabitz RG; Wolff T; Marcus C; Engelhardt W; Hörnchen H; Messmer BJ; von Bernuth G
    J Thorac Cardiovasc Surg; 1996 Apr; 111(4):882-92. PubMed ID: 8614150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low dose systemic heparinization combined with heparin-coated extracorporeal circulation. Effects related to platelets.
    Mirow N; Brinkmann T; Minami K; Tenderich G; Schulte-Eistrup S; Kleesiek K; Körfer R
    J Cardiovasc Surg (Torino); 2001 Oct; 42(5):579-85. PubMed ID: 11562580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.